Surufatinib drug page Clinical trials

Trials with Surufatinib

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
2Countries
123Planned patients

Showing 1–2 of 2

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma
Ongoing, not recruiting Phase 2 36 patients NCT05472948

To explore the safety and efficacy of Surufatinib and Sintilimab in Combination With Capecitabine in Patients With Previously Treated Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma : a Single-arm, a Single-center , Phas…

China Feb 2023 – Dec 2027 Interventional
Combined with: CapecitabineSintilimab
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Finished Phase 1 87 patients NCT04579757

This open-label, phase Ib/II study of surufatinib in combination with tislelizumab will evaluate the safety, tolerability, PK and efficacy in patients with advanced solid tumors. The study consists of 2 parts - dose finding (Part 1) and do…

United States Mar 2021 – Aug 2024 Interventional